Ignite Creation Date:
2024-05-06 @ 12:52 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03879174
Status:
UNKNOWN
Last Update Posted:
2019-03-18
First Post:
2019-03-14
Brief Title:
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation
Sponsor:
Mediclinic Middle East
Organization:
Mediclinic Middle East
Organization Data
Organization:
Mediclinic Middle East
Class:
INDUSTRY
Study ID:
ANMCMECR12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mediclinic Middle East
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None